ADVFN - Advanced Financial Network.
HOME» NYSE » A » ABT Stock Price » ABT Stock News

Abbott Labs Share News

 Abbott Laboratories Stock Price
ABT Stock Price
 Abbott Laboratories Stock Chart
ABT Stock Chart
 Abbott Laboratories Stock News
ABT Stock News
 Abbott Laboratories Company Information
ABT Company Information
 Abbott Laboratories Stock Trades
ABT Stock Trades

Abbott Ties Up With Biocon Unit To Develop Nutrition Products In India

BANGALORE -(Dow Jones)- U.S. drug maker Abbott Laboratories (ABT) has tied up with a unit of Indian biotechnology company Biocon Ltd. (532523.BY) to set up a research and development center for nutrition products. Abbott will set up the center in India in collaboration with Biocon's contract research unit, Syngene. More than 50 researchers and scientists will be based at the center, which is expected to open in June, the companies said in a joint statement Thursday. Syngene currently has a research tie-up with Bristol-Myers Squibb Co., under which it provides research and development services for the company's discovery and early drug development processes. -By Rumman Ahmed, Dow Jones Newswires; 91-9845104173; rumman.ahmed@dowjones.com

Stock News for Abbott Labs (ABT)
DateTimeHeadline
12/09/201616:51:39Current Report Filing (8-k)
12/09/201610:25:00Abbott Raising Quarterly Dividend for 45th Straight Year
12/07/201614:01:00Abbott Seeks to Terminate Alere Deal -- Update
12/07/201613:30:00Abbott Seeks to Terminate Alere Deal
12/07/201612:59:00Alere Issues Statement Regarding Abbott Lawsuit
12/07/201612:54:00Abbott Seeks to Terminate Alere Deal
12/07/201611:14:00Abbott Seeks to Terminate Alere Acquisition
12/06/201608:00:00Study: Hospital Nutrition Program Shortens Patient Stays and...
11/30/201607:00:00Abbott Announces CE Mark for i-STAT Alinity, a Pioneering, Handheld...
11/23/201609:01:43Current Report Filing (8-k)
11/21/201606:02:19Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/18/201617:03:53Statement of Changes in Beneficial Ownership (4)
11/18/201606:02:59Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
11/17/201609:15:00Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/17/201609:07:46Current Report Filing (8-k)
11/17/201608:45:00Biotech Stocks Forge Ahead With Confidence on This Week's Healthy...
11/17/201602:00:50Aqua Bio Technology: Increased income and EBITDA in 3rd quarter...
11/16/201617:22:00Current Report Filing (8-k)
11/14/201610:05:48Statement of Changes in Beneficial Ownership (4)
11/14/201610:05:22Statement of Changes in Beneficial Ownership (4)

Abbott Laboratories and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US